229 related articles for article (PubMed ID: 12818727)
1. Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages.
Piver B; Berthou F; Dreano Y; Lucas D
Life Sci; 2003 Jul; 73(9):1199-213. PubMed ID: 12818727
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components.
Piver B; Berthou F; Dreano Y; Lucas D
Toxicol Lett; 2001 Dec; 125(1-3):83-91. PubMed ID: 11701226
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibitory effect of alpha-viniferin on human cytochrome P450.
Sim J; Jang HW; Song M; Kim JH; Lee SH; Lee S
Food Chem Toxicol; 2014 Jul; 69():276-80. PubMed ID: 24769006
[TBL] [Abstract][Full Text] [Related]
4. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes.
Billard C; Izard JC; Roman V; Kern C; Mathiot C; Mentz F; Kolb JP
Leuk Lymphoma; 2002 Oct; 43(10):1991-2002. PubMed ID: 12481898
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol and its dimers ε-viniferin and δ-viniferin in red wine protect vascular endothelial cells by a similar mechanism with different potency and efficacy.
Wu CW; Nakamoto Y; Hisatome T; Yoshida S; Miyazaki H
Kaohsiung J Med Sci; 2020 Jul; 36(7):535-542. PubMed ID: 32118360
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.
Ueng YF; Hsieh CH; Don MJ
Food Chem Toxicol; 2005 May; 43(5):707-12. PubMed ID: 15778010
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
10. In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1.
Schwarz D; Roots I
Biochem Biophys Res Commun; 2003 Apr; 303(3):902-7. PubMed ID: 12670496
[TBL] [Abstract][Full Text] [Related]
11. Greater effectiveness of ε-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration.
Zghonda N; Yoshida S; Araki M; Kusunoki M; Mliki A; Ghorbel A; Miyazaki H
Biosci Biotechnol Biochem; 2011; 75(7):1259-67. PubMed ID: 21737923
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
[TBL] [Abstract][Full Text] [Related]
13. Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors.
Hyrsova L; Vanduchova A; Dusek J; Smutny T; Carazo A; Maresova V; Trejtnar F; Barta P; Anzenbacher P; Dvorak Z; Pavek P
Toxicol Lett; 2019 Jan; 300():81-91. PubMed ID: 30394306
[TBL] [Abstract][Full Text] [Related]
14. The Differential Effects of Resveratrol and trans-ε-Viniferin on the GABA-Induced Current in GABAA Receptor Subtypes Expressed in Xenopus Laevis Oocytes.
Groundwater PW; Hamid K; Ng I; Tallapragada VJ; Hibbs DE; Hanrahan J
J Pharm Pharm Sci; 2015; 18(4):328-38. PubMed ID: 26626239
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human liver cytochrome P450 by star fruit juice.
Zhang JW; Liu Y; Cheng J; Li W; Ma H; Liu HT; Sun J; Wang LM; He YQ; Wang Y; Wang ZT; Yang L
J Pharm Pharm Sci; 2007; 10(4):496-503. PubMed ID: 18261370
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.
Chan WK; Delucchi AB
Life Sci; 2000 Nov; 67(25):3103-12. PubMed ID: 11125847
[TBL] [Abstract][Full Text] [Related]
18. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.
Yu C; Shin YG; Kosmeder JW; Pezzuto JM; van Breemen RB
Rapid Commun Mass Spectrom; 2003; 17(4):307-13. PubMed ID: 12569440
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
